Showing results (11-20 of 21,659) with videos related to

Sort By:
Pageof 2,166
ACS Infectious Diseases|September 19, 2019
A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68Chunlong Ma, Yanmei Hu, Jiantao Zhang, et al.
Current Medicinal Chemistry|July 10, 2018
Focusing on the Influenza Virus Polymerase Complex: Recent Progress in Drug Discovery and Assay DevelopmentJiantao Zhang, Yanmei Hu, Rami Musharrafieh, et al.
Journal of Medicinal Chemistry|May 27, 2022
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like ProteaseHaozhou Tan, Yanmei Hu, Prakash Jadhav, et al.
European Journal of Medicinal Chemistry|April 24, 2017
Design and expeditious synthesis of organosilanes as potent antivirals targeting multidrug-resistant influenza A virusesYanmei Hu, Yuanxiang Wang, Fang Li, et al.
ACS Infectious Diseases|April 11, 2022
Drug-Repurposing Screening Identified Tropifexor as a SARS-CoV-2 Papain-like Protease InhibitorChunlong Ma, Yanmei Hu, Yuyin Wang, et al.
Accounts of Chemical Research|December 29, 2022
SARS-CoV-2 Main Protease Drug Design, Assay Development, and Drug Resistance StudiesBin Tan, Ryan Joyce, Haozhou Tan, et al.
ACS Infectious Diseases|September 23, 2016
Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton ChannelFang Li, Chunlong Ma, Yanmei Hu, et al.
Pageof 2,166